🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This proof of concept study is designed to evaluate the efficacy and safety...
Status
Terminated
Location
Addenbrookes Hospital
Start Date
2008-03
Trial ID
NCT00542269
Treatments Being Tested
The purpose of the study was to evaluate the efficacy (blood pressure lower...
Status
Completed
Location
Investigative Site
Start Date
2010-10
Trial ID
NCT01237223
The study will evaluate the efficacy and safety of both aliskiren monothera...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-03
Trial ID
NCT00853658
This study will compare the blood pressure (BP) lowering effect of the comb...
Status
Completed
Location
Investigative Site
Start Date
2009-01
Trial ID
NCT00841672
Treatments Being Tested
This study will evaluate the efficacy and safety of aliskiren 75 mg, 150 mg...
Status
Completed
Location
Investigative Site
Start Date
2008-05
Trial ID
NCT00706134
Treatments Being Tested
This prospective multicenter, double blind study will evaluate the efficacy...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-11
Trial ID
NCT01042392
Treatments Being Tested
The core and extension studies assessed the safety and efficacy of aliskire...
Status
Completed
Location
Novartis US
Start Date
2006-12
Trial ID
NCT00414609
In addition to the blood pressure lowering effects of aliskiren, it may hav...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-05
Trial ID
NCT00923156
Treatments Being Tested
This study is designed to compare the blood pressure lowering efficacy of a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT01922141
Treatments Being Tested
Inflammation of the blood vessel plays an important role in the development...
Status
Terminated
Location
VU University Medical Center
Start Date
2011-09
Trial ID
NCT01425242
Treatments Being Tested